Skip to main content

Intuitive Surgical (ISRG): 3 Reasons We Love This Stock

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ISRG Cover Image

Over the last six months, Intuitive Surgical’s shares have sunk to $400.75, producing a disappointing 17.5% loss - a stark contrast to the S&P 500’s 13% gain. This might have investors contemplating their next move.

Given the weaker price action, is now a good time to buy ISRG? Find out in our full research report, it’s free.

Why Are We Positive on ISRG?

Pioneering minimally invasive surgery since its first da Vinci system was FDA-cleared in 2000, Intuitive Surgical (NASDAQ: ISRG) develops and manufactures robotic-assisted surgical systems that enable minimally invasive procedures across various medical specialties.

1. Long-Term Revenue Growth Shows Strong Momentum

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, Intuitive Surgical grew its sales at a solid 16.4% compounded annual growth rate. Its growth surpassed the average healthcare company and shows its offerings resonate with customers.

Intuitive Surgical Quarterly Revenue

2. Outstanding Long-Term EPS Growth

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Intuitive Surgical’s astounding 17.4% annual EPS growth over the last five years aligns with its revenue performance. This tells us its incremental sales were profitable.

Intuitive Surgical Trailing 12-Month EPS (Non-GAAP)

3. Increasing Free Cash Flow Margin Juices Financials

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Intuitive Surgical’s margin expanded by 7.5 percentage points over the last five years. This is encouraging, and we can see it became a less capital-intensive business because its free cash flow profitability rose more than its operating profitability. Intuitive Surgical’s free cash flow margin for the trailing 12 months was 29.2%.

Intuitive Surgical Trailing 12-Month Free Cash Flow Margin

Final Judgment

These are just a few reasons why we’re bullish on Intuitive Surgical. After the recent drawdown, the stock trades at 35.5× forward P/E (or $400.75 per share). Is now the right time to buy? See for yourself in our full research report, it’s free.

Stocks We Like Even More Than Intuitive Surgical

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  265.13
-2.15 (-0.80%)
AAPL  305.26
+3.01 (1.00%)
AMD  483.01
+0.08 (0.02%)
BAC  64.09
-0.72 (-1.11%)
GOOG  343.94
+1.57 (0.46%)
META  594.97
+16.12 (2.78%)
MSFT  496.88
+4.45 (0.90%)
NVDA  225.30
+1.21 (0.54%)
ORCL  156.22
+2.94 (1.92%)
TSLA  339.96
+12.45 (3.80%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.